Table 2.
Patient Demographics
| HGOC Patients (N=1636) | ||
|---|---|---|
| N | % | |
| Race | ||
| White | 1266 | 77.4 |
| Asian | 100 | 6.1 |
| Black | 97 | 5.9 |
| American Indian/Alaska native | 2 | 0.1 |
| Native Hawaiian/Pacific Islander | 1 | 0.1 |
| Other/not reported | 170 | 10.4 |
| Religion | ||
| Christian | 1252 | 76.5 |
| Jewish | 37 | 2.3 |
| Muslim | 27 | 1.6 |
| Buddhist | 16 | 1.0 |
| Hindu | 21 | 1.3 |
| Other/not reported | 283 | 17.3 |
| Age at HGOC diagnosis, years | ||
| <20 | 0 | 0.0 |
| 20–29 | 10 | 0.6 |
| 30–39 | 58 | 3.6 |
| 40–49 | 255 | 15.6 |
| 50–59 | 527 | 32.2 |
| 60–69 | 506 | 30.9 |
| 70–79 | 227 | 13.9 |
| ≥80 | 53 | 3.2 |
| HGOC histology | ||
| Serous component | 1323 | 80.9 |
| Clear cell component | 141 | 8.6 |
| Endometrioid component | 96 | 5.9 |
| Mullerian carcinoma, NOS | 76 | 4.6 |
| Type of care received | ||
| Cancer treatment | 722 | 44.1 |
| Treatment planning and coordination | 258 | 15.8 |
| One-time second opinion only | 656 | 40.1 |
Abbreviations: HGOC, high-grade, non-mucinous epithelial ovarian, fallopian tube, and primary peritoneal cancers; NOS, not otherwise specified